The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis - PubMed (original) (raw)

The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis

Ibrahim A Hanouneh et al. Clin Gastroenterol Hepatol. 2014 Mar.

Abstract

Background & aims: Selected-ion flow-tube mass spectrometry can precisely identify trace gases in the human breath, in the parts-per-billion range. We investigated whether concentrations of volatile compounds in breath samples correlate with the diagnosis of alcoholic hepatitis (AH) and the severity of liver disease in patients with AH.

Methods: We recruited patients with liver disease from a single tertiary care center. The study population was divided between those with AH with cirrhosis (n = 40) and those with cirrhosis with acute decompensation from etiologies other than alcohol (n = 40); individuals without liver disease served as control subjects (n = 43). We used selected-ion flow-tube mass spectrometry to identify and measure 14 volatile compounds in breath samples from fasted subjects. We used various statistical analyses to compare clinical characteristics and breath levels of compounds among groups and to test the correlation between levels of compounds and severity of liver disease. Logistic regression analysis was performed to build a predictive model for AH.

Results: We identified 6 compounds (2-propanol, acetaldehyde, acetone, ethanol, pentane, and trimethylamine [TMA]) whose levels were increased in patients with liver disease compared with control subjects. Mean concentrations of TMA and pentane (TAP) were particularly high in breath samples from patients with AH, compared with those with acute decompensation or control subjects (for both, P < .001). Using receiver operating characteristic curve analysis, we developed a model for the diagnosis of AH based on breath levels of TAP. TAP scores of 36 or higher identified the patients with AH (area under the receiver operating characteristic curves = 0.92) with 90% sensitivity and 80% specificity. The levels of exhaled TMA had a low level of correlation with the severity of AH based on model for end-stage liver disease score (r = 0.38; 95% confidence interval, 0.07-0.69; P = .018).

Conclusions: Based on levels of volatile compounds in breath samples, we can identify patients with AH vs patients with acute decompensation or individuals without liver disease. Levels of exhaled TMA moderately correlate with the severity of AH. These findings might be used in diagnosis of AH or in determining patient prognosis.

Keywords: Alcohol Consumption; Liver Damage; Marker Panel; Microbiota.

Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest:

  1. -
    Ibrahim Hanouneh: None to declare.
  2. -
    David Grove: None to declare.
  3. -
    Luma Dababneh: None to declare.
  4. -
    Naim Alkhouri: None to declare.
  5. -
    Rocio Lopez: None to declare.
  6. -
    Frank Cikach: None to declare.
  7. -
    Nizar Zein: None to declare.
  8. -
    Raed Dweik: None to declare.

Figures

Figure 1

Figure 1

Metabolism of dietary phosphatidylcholine

Figure 2

Figure 2

ROC Analysis of the Breathprint for the Diagnosis of Alcoholic Hepatitis. TMA= trimethylamine

Comment in

Similar articles

Cited by

References

    1. Manning DS, Afdhal NH. Diagnosis and quantitation of fibrosis. Gastroenterology. 2008;134:1670–1681. - PubMed
    1. Poniachik J, Bernstein DE, Reddy KR, et al. The role of laparoscopy in the diagnosis of cirrhosis. Gastrointestinal Endoscopy. 1996;vol.43(no.6):568–571. - PubMed
    1. Paschke KM, Mashir A, Dweik RA. Clinical applications of breath testing. F1000 Med Rep. 2010 Jul 22;2:56. - PMC - PubMed
    1. Ross BM. Sub-parts per billion detection of trace volatile chemicals in human breath using Selected Ion Flow Tube Mass Spectrometry. BMC Res Notes. 2008;1:41. - PMC - PubMed
    1. Klatt S, Taut C, Mayer D, Adler G, Beckh K. Evaluation of the C-methacetin breath test for quantitative liver function testing Evaluation des C-methacetin-atemtests als quantitativer leberfunktionstest. Zeitschrift fur Gastroenterologie. 1997;vol.35(no.8):609–614. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources